| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.6 | 0.0003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.56 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |